Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada flag Canada · Delayed Price · Currency is CAD
0.1150
+0.0050 (4.55%)
Sep 8, 2025, 9:58 AM EDT

Pharmala Biotech Holdings Revenue

Pharmala Biotech Holdings had revenue of 135.17K CAD in the quarter ending May 31, 2025, a decrease of -6.48%. This brings the company's revenue in the last twelve months to 420.81K, down -69.75% year-over-year. In the fiscal year ending August 31, 2024, Pharmala Biotech Holdings had annual revenue of 1.04M with 94.60% growth.

Revenue (ttm)
420.81K
Revenue Growth
-69.75%
P/S Ratio
27.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
11.73M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 20241.04M503.29K94.60%
Aug 31, 2023532.00K453.93K581.44%
Aug 31, 202278.07K--
Aug 31, 2021---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition